title: Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
authors.affiliation: University Children's Hospital Tübingen, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Bader
authors.forename: G
authors.initials: G
authors.lastname: Dückers
authors.forename: H
authors.initials: H
authors.lastname: Kreyenberg
authors.forename: W
authors.initials: W
authors.lastname: Hoelle
authors.forename: G
authors.initials: G
authors.lastname: Kerst
authors.forename: P
authors.initials: P
authors.lastname: Lang
authors.forename: J
authors.initials: J
authors.lastname: Greil
authors.forename: D
authors.initials: D
authors.lastname: Niethammer
authors.forename: L F
authors.initials: LF
authors.lastname: Beck
authors.forename: T
authors.initials: T
authors.lastname: Klingebiel
mesh_terms: D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage; D018572:Disease-Free Survival; D006086:Graft vs Host Disease / Q000453:epidemiology; D020544:Graft vs Leukemia Effect; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007167:Immunotherapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012008:Recurrence; D033581:Stem Cell Transplantation; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine